FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Taro Pharmaceuticals U.S.A. Warfarin Sodium Tablets Recall

Warfarin Sodium Tablets, USP Crystalline, 2 mg, 100 and 1000 Tablet Bottles, Rx Only

Taro Pharmaceuticals U.S.A., Inc. · Hawthorne, NY

Risk level
Class III
Reported by FDA
Sep 24, 2014
Recall ID
D-1584-2014
Check your lot numberHow we source this data

Summary

Taro Pharmaceuticals U.S.A. recalled Warfarin Sodium Tablets starting Aug 25, 2014. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1584-2014 on Sep 24, 2014. Reason: Failed Content Uniformity Specifications. Status: Terminated.

Why it was recalled

Failed Content Uniformity Specifications.

Product description

Warfarin Sodium Tablets, USP Crystalline, 2 mg, 100 and 1000 Tablet Bottles, Rx Only. Mfd. by: Taro Pharmaceutical Industries, Ltd., Haifa Bay, Israel 26110. Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. 100 Tablet Bottle NDC: 51672-4028-1, 1000 Tablet Bottle NDC: 51672-4028-3.

Lot numbers, UPCs & expiration codes

Lot #: 149400, Expiry: January 2016; Lot #: 149649, Expiry: January 2016.

Where it was sold

United States including: OH, HI, NH, MS, IL, TX, CA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1584-2014
Classification
Class III
Status
Terminated
Recall initiated
Aug 25, 2014
FDA report date
Sep 24, 2014
Quantity
1396 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Taro Pharmaceuticals U.S.A., Inc.

Original FDA data

Every field from FDA enforcement report D-1584-2014, exactly as published.

Show all FDA fields
City
Hawthorne
State
NY
Status
Terminated
Country
United States
Event ID
69075
Address
3 Skyline Dr
Code information
Lot #: 149400, Expiry: January 2016; Lot #: 149649, Expiry: January 2016.
Postal code
10532-2174
Report date
Sep 24, 2014
Product type
Drugs
Recall number
D-1584-2014
Classification
Class III
Recalling firm
Taro Pharmaceuticals U.S.A., Inc.
Product quantity
1396 Bottles
Termination date
May 18, 2018
Reason for recall
Failed Content Uniformity Specifications.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Warfarin Sodium Tablets, USP Crystalline, 2 mg, 100 and 1000 Tablet Bottles, Rx Only. Mfd. by: Taro Pharmaceutical Industries, Ltd., Haifa Bay, Israel 26110. Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. 100 Tablet Bottle NDC: 51672-4028-1, 1000 Tablet Bottle NDC: 51672-4028-3.
Distribution pattern
United States including: OH, HI, NH, MS, IL, TX, CA.
Recall initiation date
Aug 25, 2014
Initial firm notification
Letter
Center classification date
Sep 12, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1584-2014, published Sep 24, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls